Filing Flows › Myomo (MYO) › Q1 2026 › vs Q4 2025
Myomo (MYO) Q1 2026 vs Q4 2025 (quarter over quarter)
Myomo's revenue fell $1.2M (-11%) from $11.4M in Q4 2025 to $10.1M in Q1 2026.
Myomo, Q1 2026: revenue $10.1M (+3% year over year), operating margin -31.2%, net loss $3.0M, operating cash flow −$2.2M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $10.1M | $11.4M | −$1.2M | -11% |
| Other income, net | $334K | −$956K | $1.3M | — |
| Net loss | $3.0M | $3.8M | −$805K | -21% |
| Costs & expenses | $13.5M | $15.2M | −$1.7M | -11% |
| Operating costs | $13.3M | $14.1M | −$857K | -6% |
| Income tax | $187K | $84K | $103K | +123% |
| Cost of revenue | $3.2M | $3.6M | −$357K | -10% |
| Research & development | $1.6M | $1.6M | −$2K | -0.1% |
| Sales & marketing | $4.8M | $5.5M | −$684K | -12% |
| General & admin | $3.6M | $3.4M | $187K | +5% |
| Operating cash sources | $3.1M | $2.0M | $1.1M | +57% |
| Depreciation & amortization | $292K | $263K | $28K | +11% |
| Share-based compensation | $597K | $565K | $32K | +6% |
| Cash used in operations | $2.2M | $1.1M | $1.1M | +93% |
| Net loss absorbed | $3.0M | $3.8M | −$805K | -21% |
| Working capital & other | $77K | −$1.8M | $1.9M | — |
Questions
How much did Myomo's revenue grow quarter over quarter in Q1 2026?
Myomo's revenue fell $1.2M (-11%) from $11.4M in Q4 2025 to $10.1M in Q1 2026.